NORLIQVA
- Product NDC
- 46287-035
- 11-digit product format
- 462870035
- Labeler code
- 46287
- Product ID
- 46287-035_63a6bb49-fb68-4351-be5f-a6b6e8f6b540
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- amlodipine
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- CMP Pharma, Inc.
- Application
- NDA214439
- Marketing category
- NDA
- Marketing start
- 2022-04-15
- Substance
- AMLODIPINE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NORLIQVA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AMLODIPINE | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1J444QC288 |
| Rxcui | 2599173, 2599179 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 46287-035-15 | NORLIQVA | 150 mL in 1 BOTTLE | Solution | 150 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 46287-035 | NORLIQVA (AMLODIPINE) SOLUTION [CMP PHARMA, INC.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220416_c1730a51-4383-4c61-a9a1-7e1326bd0abe.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 46287-035-15 | 46287003515 | 150 mL in 1 BOTTLE (46287-035-15) | 150 ml | 2022-04-15 | 0000-00-00 | No | No | Current |